Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology

201993 citationsReview

Authors

Good health and well-being

Published in: Drug Safety

Volume 42, Issue 2, pp. 181-198

Field-Weighted Citation Impact: 8.54